Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.686 USD | -0.50% | +4.53% | -36.04% |
20/05 | Entero Therapeutics, Inc.(NasdaqCM:ENTO) added to NASDAQ Composite Index | CI |
17/05 | First Wave BioPharma, Inc. will Change its Name to Entero Therapeutics, Inc | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.04% | 66.83L | |
+48.85% | 5.46TCr | |
-4.46% | 3.99TCr | |
+37.15% | 3.88TCr | |
+16.05% | 2.69TCr | |
-12.56% | 2.62TCr | |
-21.79% | 1.88TCr | |
+26.15% | 1.22TCr | |
+2.46% | 1.22TCr | |
+26.97% | 1.19TCr |
- Stock Market
- Equities
- ENTO Stock
- News Entero Therapeutics, Inc.
- AzurRx BioPharma : Roth Capital Adjusts Price Target on AzurRx BioPharma to $5 From $7, Maintains Buy Rating